Dallas- & NY-Based Conflixis Raises $4.2M Seed Funding to Transform Healthcare Conflicts-of-Interest Management

Conflixis said the funding will advance its mission to improve the healthcare ecosystem by ensuring every financial relationship is known, contextualized, and its influence on procurement, operational, and medical decisions understood.

Data and risk intelligence company Conflixis Inc. announced a $4.2 million in seed capital funding round co-led by Lerer Hippeau and Origin Ventures, with additional investment from mark vc, Springtime Ventures, and continued support from early investor Crētiv Capital.

The company, based in New York City and Dallas, said the funding will advance its mission to improve the healthcare ecosystem by ensuring every financial relationship is known, contextualized, and its influence on procurement, operational, and medical decisions understood.

“The Conflixis platform helps large healthcare organizations identify and understand the role that conflicting financial relationships play in medical and operational decisions,” Dallas-based CEO Aaron Narva said in a statement. “Collaboration between healthcare providers, innovators, and industry is absolutely critical for continued technological and scientific advancement. Transparency around these relationships is good for all stakeholders and will result in better decision-making at healthcare organizations of all kinds.”

Conflixis said it has developed a unified platform that combines traditional COI management functionality with proprietary risk models and advanced analytics—empowering some of the largest health systems and practice groups with “unparalleled insight” into how even the most complex relationships influence their decisions.

The company said this latest investment will further accelerate the platform’s growth by dramatically expanding Conflixis’ library of evidence-based influence models, including predictive spend capabilities powered by peer-reviewed data.

Investment and attention will also be placed on expanding the company’s client-facing and R&D teams.

What the investors said

“We’re excited to partner with Aaron and team as they tackle the massive issue of illuminating conflicts of interest in healthcare,” Graham Brown, managing partner at Lerer Hippeau, said in a statement. “In a single year, Conflixis has demonstrated product market fit across a range of healthcare stakeholders, including major health systems and large practice groups. This next tranche of funding will give Conflixis the opportunity to execute on their roadmap and continue to drive growth, for the benefit of patients, payers, and large healthcare organizations, alike.”

Origin Ventures Principal Jacquie Marshall Siegmund said Conflixis is at the vanguard of something vital.

“We see a tremendous opportunity in using data for smarter decision-making in healthcare. Conflixis is at the forefront of this transformation, providing innovative solutions that address critical challenges in conflicts management,” Siegmund said.

“We have had a front row seat to Conflixis’ fast-growing position in a market ripe for change,” Noah Zaltz, co-founder and managing partner at Crētiv Capital, said in a statement. “The Conflixis platform goes way beyond compliance—rethinking the value of financial transparency to the bottom lines of healthcare organizations—and, more importantly—to the long-term impacts on patient outcomes.”

Get on the list.
Dallas Innovates, every day.

Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.

One quick signup, and you’re done.  

R E A D   N E X T

  • Mobility startups from coast to coast—including those focused on innovative ideas to transport people or goods—are invited to apply.  The unique accelerator program supports startups in the automotive ecosystem, ranging from AI-powered industry solutions and transportation infrastructure to dealer support and related services.

  • Vann's news: Impact Ventures "will be considered 1 of 74 [Community Development Venture Capital] firms in the U.S."—and the second in Texas—"providing more small businesses access to equity and equity-like capital, especially in times like today where interest rates are higher and traditional debt is considered to be expensive."

  • In 2023, founders searching for venture capital found fewer investors and less money. Pitchbook reports that the number of U.S. deals in the first three quarters of 2023 was just slightly higher than the number made during the same period in 2018.   In North Texas, it was a similar story. But even as investment markets have tightened, Dallas-based Beyond Capital is working to reverse that trend by investing in more startups. In the first quarter of 2024, it’s opening its third fund to new investors.   Beyond Capital looks for startups in need of Seed to Series A investment. What…

  • In a world reshaped by remote work and virtual services, do Americans still believe that owning a car is essential to getting ahead? Researchers investigated how vehicle ownership impacts upward mobility post-pandemic—from employment to social benefits.

  • Featuring leaders like Jesse Draper of Halogen Ventures, Jim Lee of the Texas Stock Exchange, and Christopher Darby, former CEO of In-Q-Tel, the October 30 event at the Bush Center in Dallas will focus on emerging trends in sectors such as healthcare, national security, and the creator economy.